Digest Network Come funziona
Network
/
Società
Av
Non verificato

Avenacy

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaSaluteSanità

28 comunicati stampa

Guarda tutti i comunicati
08/09/2026
Multimedialità
Industria
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
Attrezzature medico-sanitarie
Medicina - Varie
Avenacy Announces Launch of Cyclophosphamide for Injection, USP in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
29/06/2026
Avenacy Announces Launch of Norepinephrine Bitartrate Injection, USP in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
17/06/2026
Avenacy Announces Launch of Bortezomib for Injection in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
11/05/2026
Avenacy Announces Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
16/03/2026
Eventi
Biotecnologia
Farmaceutica
Salute
Avenacy to Attend 2026 DCAT Week
Fonte
Avenacy
Emittente
Business Wire
1.00
0
02/03/2026
Avenacy Announces Launch of Diphenhydramine Hydrochloride Injection, USP in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
08/01/2026
Eventi
Biotecnologia
Sanità
Farmaceutica
Salute
Avenacy Provides Update on Business Progress and Announces 2026 Strategic Priorities Ahead of 44th Annual J.P. Morgan Healthcare Conference
Fonte
Avenacy
Emittente
Business Wire
1.00
0
17/12/2025
Eventi
Biotecnologia
Farmaceutica
Salute
Avenacy to Attend J.P. Morgan 44th Annual Healthcare Conference
Fonte
Avenacy
Emittente
Business Wire
1.00
0
03/12/2025
Farmaceutica
Salute
Sanità
Attrezzature medico-sanitarie
Eventi
Industria
Avenacy to Attend 2025 ASHP Midyear Clinical Meeting and Exhibition
Fonte
Avenacy
Emittente
Business Wire
1.00
0
22/10/2025
Eventi
Fiere
Salute
Farmaceutica
Avenacy to Highlight 2025 Achievements and Partnership Opportunities at CPHI Frankfurt
Fonte
Avenacy
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0